Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: REGENERON PHARMACEUTICALS INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2021-01-12 to 2022-07-31
Current total value of award: $5565000000
Description: TRANSFER OF REMAINING REGEN-COV DOSES TO POTA W15QKN-16-9-1002, PROTOTYPE PROJECT MCDC 2008-005